0
     

Report Added
Report already added
Transdermal Drug Delivery System Market in India - Industry Outlook and Forecast 2020-2026

Transdermal Drug Delivery System Market in India - Industry Outlook and Forecast 2020-2026

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive._x000D_
_x000D_
This report contains market size and forecasts of Transdermal Drug Delivery System in India, including the following market information:_x000D_
India Transdermal Drug Delivery System Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
Top Five Competitors in India Transdermal Drug Delivery System Market 2019 (%)_x000D_
The global Transdermal Drug Delivery System market was valued at 11960 million in 2019 and is projected to reach US$ 19320 million by 2026, at a CAGR of 12.7% during the forecast period. While the Transdermal Drug Delivery System market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
COVID-19 pandemic has big impact on Transdermal Drug Delivery System businesses, with lots of challenges and uncertainty faced by many players of Transdermal Drug Delivery System in India. This report also analyses and evaluates the COVID-19 impact on Transdermal Drug Delivery System market size in 2020 and the next few years in India_x000D_
Total Market by Segment:_x000D_
India Transdermal Drug Delivery System Market, By Type, 2015-2020, 2021-2026 ($ millions)_x000D_
India Transdermal Drug Delivery System Market Segment Percentages, By Type, 2019 (%)_x000D_
Fentanyl_x000D_
Nitroglycerin_x000D_
Estradiol_x000D_
Nicotine_x000D_
Other_x000D_
_x000D_
India Transdermal Drug Delivery System Market, By Application, 2015-2020, 2021-2026 ($ millions)_x000D_
India Transdermal Drug Delivery System Market Segment Percentages, By Application, 2019 (%)_x000D_
OTC_x000D_
Rx_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Transdermal Drug Delivery System Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Transdermal Drug Delivery System Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Hisamitsu_x000D_
Mylan_x000D_
GSK_x000D_
Novartis_x000D_
Teve (Actavis)_x000D_
Johnson & Johnson_x000D_
Lohmann_x000D_
Teikoku Seiyaku_x000D_
Bayer_x000D_
Lingrui_x000D_
Sanofi_x000D_
Qizheng_x000D_
Endo_x000D_
Huarun 999_x000D_
Haw Par_x000D_
Nichiban_x000D_
Mentholatum_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Transdermal Drug Delivery System Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 COVID-19 Impact: India Transdermal Drug Delivery System Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 India Transdermal Drug Delivery System Overall Market Size_x000D_
2.1 India Transdermal Drug Delivery System Market Size: 2020 VS 2026_x000D_
2.2 India Transdermal Drug Delivery System Revenue, Prospects & Forecasts: 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Transdermal Drug Delivery System Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Transdermal Drug Delivery System Companies Ranked by Revenue_x000D_
3.3 India Transdermal Drug Delivery System Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 Top 3 and Top 5 Transdermal Drug Delivery System Companies in India, by Revenue in 2019_x000D_
3.5 India Manufacturers Transdermal Drug Delivery System Product Type_x000D_
3.6 Tier 1, Tier 2 and Tier 3 Transdermal Drug Delivery System Players in India_x000D_
3.6.1 List of India Tier 1 Transdermal Drug Delivery System Companies_x000D_
3.6.2 List of India Tier 2 and Tier 3 Transdermal Drug Delivery System Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Transdermal Drug Delivery System Market Size Markets, 2020 & 2026_x000D_
4.1.2 Fentanyl_x000D_
4.1.3 Nitroglycerin_x000D_
4.1.4 Estradiol_x000D_
4.1.5 Nicotine_x000D_
4.1.6 Other_x000D_
4.2 By Type - India Transdermal Drug Delivery System Revenue & Forecasts_x000D_
4.2.1 By Type - India Transdermal Drug Delivery System Revenue, 2015-2020_x000D_
4.2.2 By Type - India Transdermal Drug Delivery System Revenue, 2021-2026_x000D_
4.2.3 By Type - India Transdermal Drug Delivery System Revenue Market Share, 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Transdermal Drug Delivery System Market Size, 2020 & 2026_x000D_
5.1.2 OTC_x000D_
5.1.3 Rx_x000D_
5.2 By Application - India Transdermal Drug Delivery System Revenue & Forecasts_x000D_
5.2.1 By Application - India Transdermal Drug Delivery System Revenue, 2015-2020_x000D_
5.2.2 By Application - India Transdermal Drug Delivery System Revenue, 2021-2026_x000D_
5.2.3 By Application - India Transdermal Drug Delivery System Revenue Market Share, 2015-2026_x000D_
6 Players Profiles_x000D_
6.1 Hisamitsu_x000D_
6.1.1 Hisamitsu Corporate Summary_x000D_
6.1.2 Hisamitsu Business Overview_x000D_
6.1.3 Hisamitsu Transdermal Drug Delivery System Major Product Offerings_x000D_
6.1.4 Hisamitsu Revenue in India (2015-2020)_x000D_
6.1.5 Hisamitsu Key News_x000D_
6.2 Mylan_x000D_
6.2.1 Mylan Corporate Summary_x000D_
6.2.2 Mylan Business Overview_x000D_
6.2.3 Mylan Transdermal Drug Delivery System Major Product Offerings_x000D_
6.2.4 Mylan Revenue in India (2015-2020)_x000D_
6.2.5 Mylan Key News_x000D_
6.3 GSK_x000D_
6.3.1 GSK Corporate Summary_x000D_
6.3.2 GSK Business Overview_x000D_
6.3.3 GSK Transdermal Drug Delivery System Major Product Offerings_x000D_
6.3.4 GSK Revenue in India (2015-2020)_x000D_
6.3.5 GSK Key News_x000D_
6.4 Novartis_x000D_
6.4.1 Novartis Corporate Summary_x000D_
6.4.2 Novartis Business Overview_x000D_
6.4.3 Novartis Transdermal Drug Delivery System Major Product Offerings_x000D_
6.4.4 Novartis Revenue in India (2015-2020)_x000D_
6.4.5 Novartis Key News_x000D_
6.5 Teve (Actavis)_x000D_
6.5.1 Teve (Actavis) Corporate Summary_x000D_
6.5.2 Teve (Actavis) Business Overview_x000D_
6.5.3 Teve (Actavis) Transdermal Drug Delivery System Major Product Offerings_x000D_
6.5.4 Teve (Actavis) Revenue in India (2015-2020)_x000D_
6.5.5 Teve (Actavis) Key News_x000D_
6.6 Johnson & Johnson_x000D_
6.6.1 Johnson & Johnson Corporate Summary_x000D_
6.6.2 Johnson & Johnson Business Overview_x000D_
6.6.3 Johnson & Johnson Transdermal Drug Delivery System Major Product Offerings_x000D_
6.6.4 Johnson & Johnson Revenue in India (2015-2020)_x000D_
6.6.5 Johnson & Johnson Key News_x000D_
6.7 Lohmann_x000D_
6.6.1 Lohmann Corporate Summary_x000D_
6.6.2 Lohmann Business Overview_x000D_
6.6.3 Lohmann Transdermal Drug Delivery System Major Product Offerings_x000D_
6.4.4 Lohmann Revenue in India (2015-2020)_x000D_
6.7.5 Lohmann Key News_x000D_
6.8 Teikoku Seiyaku_x000D_
6.8.1 Teikoku Seiyaku Corporate Summary_x000D_
6.8.2 Teikoku Seiyaku Business Overview_x000D_
6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Major Product Offerings_x000D_
6.8.4 Teikoku Seiyaku Revenue in India (2015-2020)_x000D_
6.8.5 Teikoku Seiyaku Key News_x000D_
6.9 Bayer_x000D_
6.9.1 Bayer Corporate Summary_x000D_
6.9.2 Bayer Business Overview_x000D_
6.9.3 Bayer Transdermal Drug Delivery System Major Product Offerings_x000D_
6.9.4 Bayer Revenue in India (2015-2020)_x000D_
6.9.5 Bayer Key News_x000D_
6.10 Lingrui_x000D_
6.10.1 Lingrui Corporate Summary_x000D_
6.10.2 Lingrui Business Overview_x000D_
6.10.3 Lingrui Transdermal Drug Delivery System Major Product Offerings_x000D_
6.10.4 Lingrui Revenue in India (2015-2020)_x000D_
6.10.5 Lingrui Key News_x000D_
6.11 Sanofi_x000D_
6.11.1 Sanofi Corporate Summary_x000D_
6.11.2 Sanofi Transdermal Drug Delivery System Business Overview_x000D_
6.11.3 Sanofi Transdermal Drug Delivery System Major Product Offerings_x000D_
6.11.4 Sanofi Revenue in India (2015-2020)_x000D_
6.11.5 Sanofi Key News_x000D_
6.12 Qizheng_x000D_
6.12.1 Qizheng Corporate Summary_x000D_
6.12.2 Qizheng Transdermal Drug Delivery System Business Overview_x000D_
6.12.3 Qizheng Transdermal Drug Delivery System Major Product Offerings_x000D_
6.12.4 Qizheng Revenue in India (2015-2020)_x000D_
6.12.5 Qizheng Key News_x000D_
6.13 Endo_x000D_
6.13.1 Endo Corporate Summary_x000D_
6.13.2 Endo Transdermal Drug Delivery System Business Overview_x000D_
6.13.3 Endo Transdermal Drug Delivery System Major Product Offerings_x000D_
6.13.4 Endo Revenue in India (2015-2020)_x000D_
6.13.5 Endo Key News_x000D_
6.14 Huarun 999_x000D_
6.14.1 Huarun 999 Corporate Summary_x000D_
6.14.2 Huarun 999 Transdermal Drug Delivery System Business Overview_x000D_
6.14.3 Huarun 999 Transdermal Drug Delivery System Major Product Offerings_x000D_
6.14.4 Huarun 999 Revenue in India (2015-2020)_x000D_
6.14.5 Huarun 999 Key News_x000D_
6.15 Haw Par_x000D_
6.15.1 Haw Par Corporate Summary_x000D_
6.15.2 Haw Par Transdermal Drug Delivery System Business Overview_x000D_
6.15.3 Haw Par Transdermal Drug Delivery System Major Product Offerings_x000D_
6.15.4 Haw Par Revenue in India (2015-2020)_x000D_
6.15.5 Haw Par Key News_x000D_
6.16 Nichiban_x000D_
6.16.1 Nichiban Corporate Summary_x000D_
6.16.2 Nichiban Transdermal Drug Delivery System Business Overview_x000D_
6.16.3 Nichiban Transdermal Drug Delivery System Major Product Offerings_x000D_
6.16.4 Nichiban Revenue in India (2015-2020)_x000D_
6.16.5 Nichiban Key News_x000D_
6.17 Mentholatum_x000D_
6.17.1 Mentholatum Corporate Summary_x000D_
6.17.2 Mentholatum Transdermal Drug Delivery System Business Overview_x000D_
6.17.3 Mentholatum Transdermal Drug Delivery System Major Product Offerings_x000D_
6.17.4 Mentholatum Revenue in India (2015-2020)_x000D_
6.17.5 Mentholatum Key News_x000D_
6.18 Laboratoires Genevrier_x000D_
6.18.1 Laboratoires Genevrier Corporate Summary_x000D_
6.18.2 Laboratoires Genevrier Transdermal Drug Delivery System Business Overview_x000D_
6.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Major Product Offerings_x000D_
6.18.4 Laboratoires Genevrier Revenue in India (2015-2020)_x000D_
6.18.5 Laboratoires Genevrier Key News_x000D_
_x000D_
7 Key Market Trends & Influences 2021-2026_x000D_
7.1 PESTLE Analysis for India Transdermal Drug Delivery System Market_x000D_
7.2 Market Opportunities & Trends_x000D_
7.3 Market Drivers_x000D_
7.4 Market Restraints_x000D_
_x000D_
8 Conclusion_x000D_
_x000D_
9 Appendix_x000D_
9.1 Note_x000D_
9.2 Examples of Clients_x000D_
9.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Transdermal Drug Delivery System in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Transdermal Drug Delivery System Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Transdermal Drug Delivery System Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Transdermal Drug Delivery System Sales by Companies, (K Units), 2015-2020_x000D_
Table 6. India Transdermal Drug Delivery System Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Transdermal Drug Delivery System Price (2015-2020) (US$/Unit)_x000D_
Table 8. India Manufacturers Transdermal Drug Delivery System Product Type_x000D_
Table 9. List of India Tier 1 Transdermal Drug Delivery System Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Transdermal Drug Delivery System Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Transdermal Drug Delivery System Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Transdermal Drug Delivery System Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Transdermal Drug Delivery System Sales in India (K Units), 2015-2020_x000D_
Table 14. By Type - Transdermal Drug Delivery System Sales in India (K Units), 2021-2026_x000D_
Table 15. By Application - Transdermal Drug Delivery System Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Transdermal Drug Delivery System Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Transdermal Drug Delivery System Sales in India, (K Units), 2015-2020_x000D_
Table 18. By Application - Transdermal Drug Delivery System Sales in India, (K Units), 2021-2026_x000D_
Table 19. Hisamitsu Corporate Summary_x000D_
Table 20. Hisamitsu Transdermal Drug Delivery System Product Offerings_x000D_
Table 21. Hisamitsu Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 22. Mylan Corporate Summary_x000D_
Table 23. Mylan Transdermal Drug Delivery System Product Offerings_x000D_
Table 24. Mylan Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 25. GSK Corporate Summary_x000D_
Table 26. GSK Transdermal Drug Delivery System Product Offerings_x000D_
Table 27. GSK Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 28. Novartis Corporate Summary_x000D_
Table 29. Novartis Transdermal Drug Delivery System Product Offerings_x000D_
Table 30. Novartis Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 31. Teve (Actavis) Corporate Summary_x000D_
Table 32. Teve (Actavis) Transdermal Drug Delivery System Product Offerings_x000D_
Table 33. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 34. Johnson & Johnson Corporate Summary_x000D_
Table 35. Johnson & Johnson Transdermal Drug Delivery System Product Offerings_x000D_
Table 36. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 37. Lohmann Corporate Summary_x000D_
Table 38. Lohmann Transdermal Drug Delivery System Product Offerings_x000D_
Table 39. Lohmann Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 40. Teikoku Seiyaku Corporate Summary_x000D_
Table 41. Teikoku Seiyaku Transdermal Drug Delivery System Product Offerings_x000D_
Table 42. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 43. Bayer Corporate Summary_x000D_
Table 44. Bayer Transdermal Drug Delivery System Product Offerings_x000D_
Table 45. Bayer Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 46. Lingrui Corporate Summary_x000D_
Table 47. Lingrui Transdermal Drug Delivery System Product Offerings_x000D_
Table 48. Lingrui Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 49. Sanofi Corporate Summary_x000D_
Table 50. Sanofi Transdermal Drug Delivery System Product Offerings_x000D_
Table 51. Sanofi Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 52. Qizheng Corporate Summary_x000D_
Table 53. Qizheng Transdermal Drug Delivery System Product Offerings_x000D_
Table 54. Qizheng Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 55. Endo Corporate Summary_x000D_
Table 56. Endo Transdermal Drug Delivery System Product Offerings_x000D_
Table 57. Endo Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 58. Huarun 999 Corporate Summary_x000D_
Table 59. Huarun 999 Transdermal Drug Delivery System Product Offerings_x000D_
Table 60. Huarun 999 Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 61. Haw Par Corporate Summary_x000D_
Table 62. Haw Par Transdermal Drug Delivery System Product Offerings_x000D_
Table 63. Haw Par Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 64. Nichiban Corporate Summary_x000D_
Table 65. Nichiban Transdermal Drug Delivery System Product Offerings_x000D_
Table 66. Nichiban Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 67. Mentholatum Corporate Summary_x000D_
Table 68. Mentholatum Transdermal Drug Delivery System Product Offerings_x000D_
Table 69. Mentholatum Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
Table 70. Laboratoires Genevrier Corporate Summary_x000D_
Table 71. Laboratoires Genevrier Transdermal Drug Delivery System Product Offerings_x000D_
Table 72. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$, Mn), (2015-2020)_x000D_
List of Figures_x000D_
Figure 1. Transdermal Drug Delivery System Segment by Type_x000D_
Figure 2. Transdermal Drug Delivery System Segment by Application_x000D_
Figure 3. India Transdermal Drug Delivery System Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Transdermal Drug Delivery System Market Size in India, (US$, Mn): 2020 VS 2026_x000D_
Figure 6. India Transdermal Drug Delivery System Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. The Top 3 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2019_x000D_
Figure 8. By Type - India Transdermal Drug Delivery System Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 9. By Type - India Transdermal Drug Delivery System Market Share, 2015-2026_x000D_
Figure 10. By Application - Transdermal Drug Delivery System Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 11. By Application - India Transdermal Drug Delivery System Market Share, 2015-2026_x000D_
Figure 12. PEST Analysis for India Transdermal Drug Delivery System Market in 2020_x000D_
Figure 13. Transdermal Drug Delivery System Market Opportunities & Trends in India_x000D_
Figure 14. Transdermal Drug Delivery System Market Drivers in India_x000D_

Kindly Fill The Form Below

Report Title: Transdermal Drug Delivery System Market in India - Industry Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW